Skip to main content
Premium Trial:

Request an Annual Quote

Bruker's Q1 Revenues Climb 14.9 Percent; Swings to Loss on Acquisition Charges

NEW YORK (GenomeWeb News) – Bruker today reported a 14.9 percent increase in first-quarter revenues, aided by a 9.9 percent currency benefit, but posted a loss due to $5.8 million in acquisition charges.
The Billerica, Mass.-based firm reported revenues of $238.4 million for the three-month period ended March 31, compared to revenues of $207.5 million in the first quarter of 2007. Bruker’s product revenues rose to $207 million from $181.6 million year over year, while service revenues increased to $30 million from $25.2 million.
The firm’s R&D spending increased 20 percent to $31.2 million from $26 million, and its SG&A expenses were up 23.1 percent at $60.2 million from $48.9 million.
Bruker posted a net loss of $685,000, or $.00 per share, compared to a profit of $14.4 million, or $.09 per share, for the first quarter of 2007. The company registered acquisition-related charges of $5.8 million during the first three months of 2008. It also announced two weeks ago that it absorbed pre-tax foreign exchange losses of around $12 million for its first quarter.
“The foreign exchange losses in the first quarter of 2008 relate primarily to the revaluation of inter-company receivables within the Bruker group, to large cash balances held by Swiss Bruker BioSpin subsidiaries in various non-CHF currencies, as well as to a CHF-denominated, short-term inter-company loan from a Swiss to a German Bruker subsidiary which was used to finance a portion of the acquisition of the Bruker BioSpin Group by Bruker Corporation,” the firm explained in a statement at the time.
Bruker completed the $1.1 billion acquisition of affiliated company Bruker BioSpin in February.
Bruker finished the quarter with $321.3 million in cash and short-term investments.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.